Eagle Health Investments’s Akero Therapeutics AKRO Stock Holding History

Eagle Health Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-226,400	Closed	-$10.7M	–	32
2025 Q3	$10.7M	Hold	226,400	–	–	2.82%	15
2025 Q2	$12.1M	Hold	226,400	–	–	2.98%	13
2025 Q1	$9.16M	Buy	+226,400	New	+$9.6M	2.38%	15

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eagle Health Investments's AKRO Position: Q4 2025 in Review

Eagle Health Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 226,400 shares — an estimated $10.7M sold.

Eagle Health Investments first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $12.1M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Eagle Health Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Eagle Health Investments sold 226,400 Akero Therapeutics shares in Q4 2025, an estimated $10.7M.
Eagle Health Investments first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
Eagle Health Investments's Akero Therapeutics position peaked at $12.1M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Eagle Health Investments's 13F filing for Q4 2025, filed 6 Feb 2026.